A federal appeals court yesterday vacated the award of $52 million to a pair of “whistleblowers” whose fraud suit on behalf of the United States against SmithKline Beecham Clinical Laboratories Inc. was settled for $325 million.

The unanimous three-judge panel found that the lower court improperly barred Justice Department lawyers from arguing that the whistleblowers were not the “original sources” of the information.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]